Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Coatings TrendsCoatings Trends
Not Confirmed
Not Confirmed
03-05 September, 2025
Not Confirmed
Not Confirmed
04-06 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Coatings TrendsCoatings Trends
Industry Trade Show
Not Confirmed
03-05 September, 2025
Industry Trade Show
Not Confirmed
04-06 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
21 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/21/3137071/0/en/UroGen-Pharma-to-Present-at-Upcoming-Investor-Conferences.html
07 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/07/3129186/0/en/UroGen-Pharma-Expands-Commercial-Portfolio-with-Launch-of-ZUSDURI-and-Reports-Second-Quarter-2025-Financial-Results.html
05 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/05/3127289/0/en/UroGen-Announces-24-Month-Duration-of-Response-of-72-2-from-the-Pivotal-Phase-3-ENVISION-Trial-of-ZUSDURI-the-First-and-Only-FDA-Approved-Medicine-for-Recurrent-Low-Grade-Intermedi.html
29 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/29/3123166/0/en/UroGen-Pharma-to-Report-Second-Quarter-2025-Financial-Results-on-Thursday-August-7th-2025.html
28 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/28/3122406/0/en/UroGen-Announces-Publication-of-Phase-3b-Study-Results-Demonstrating-the-Feasibility-of-Home-Instillation-of-ZUSDURI-for-Recurrent-Low-Grade-Intermediate-Risk-Non-Muscle-Invasive-B.html
21 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/21/3118671/0/en/UroGen-Announces-Five-Year-Long-Term-Extension-Study-of-the-OPTIMA-II-Trial-Demonstrates-Long-Term-Durability-of-Response-to-ZUSDURI-in-Patients-with-Low-Grade-Intermediate-Risk-No.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE